Zhao Xing, Zuo Li, Zhong Zhi-Qiang
Department of Immunology, Guiyang Medical College, Guiyang 550004, China.
Zhong Yao Cai. 2008 Sep;31(9):1377-80.
To study the anticancer activity of Rhodiola sachalinensis in vitro and in vivo experiments.
The effect of Rhodiola sachalinensis extracts at various concentrations on T241 fibrosarcoma cells proliferation and cytotoxic potential were measured. We divided T241 fibrosarcoma-bearing C57Bl6/J mice into two groups, the tumor inhibition rate were observed.
Rhodiola sachalinensis extracts inhibited T241 tumor cells growth in a dose-dependent manner. The concentrations of Rhodiola sachalinensis extracts from 50 microg/ml to 250 microg/ml did not reduced the survival rate of T241 tumor cells. The daily administration of Rhodiola sachalinensis resulted in a significant suppression of the growth of primary tumors, compared to control group, tumor inhibition rate in Rhodiola sachalinensis group reached 70.9%.
Rhodiola sachalinensis can inhibit T241 tumor cells growth and does not cause a direct cytotoxicity against tumor cells in vitro and in vivo.
通过体外和体内实验研究高山红景天的抗癌活性。
测定不同浓度的高山红景天提取物对T241纤维肉瘤细胞增殖和细胞毒性的影响。将接种T241纤维肉瘤的C57Bl6/J小鼠分为两组,观察肿瘤抑制率。
高山红景天提取物以剂量依赖方式抑制T241肿瘤细胞生长。50微克/毫升至250微克/毫升浓度的高山红景天提取物未降低T241肿瘤细胞的存活率。与对照组相比,每日给予高山红景天可显著抑制原发性肿瘤生长,高山红景天组的肿瘤抑制率达到70.9%。
高山红景天可抑制T241肿瘤细胞生长,且在体外和体内均不会对肿瘤细胞产生直接细胞毒性。